Skip to main content
SpringerLink
Log in

Gaps in cardiovascular medication taking

The tip of the iceberg

  • Original Articles
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

Abstract

Objective: To search for major gaps in medication-taking behavior predisposing patients to cardiovascular morbidity and mortality.

Design: Convenience sample; cohort prospectively followed for ≤5 months.

Setting: General internal medicine and cardiology clinics in a university medical center.

Patients: From among 893 patients, the authors identified 132 eligible individuals and entered 33 subjects (25%) with chronic cardiovascular conditions, 1–3 chronic oral medications for these conditions, overall regimen of ≤6 drugs, regular visits at 1–3-month intervals, literacy in English, willingness to use electronic monitors, and physician permission to participate.

Outcome measures: Medication compliance rates and patterns by patient self-report, physician estimates, pill count, and electronic monitoring of pill vial opening.

Results: Despite moderately complex regimens (5.4±0.5 pills daily; range 1–11), most subjects took most medications according to the prescription: median intervals between pill vial openings were 1.00, 0.50, and 0.43 days for once, twice, and three times daily dosing, respectively. Medication-taking gaps of ≥2 times the prescribed interdosing interval occurred for 48% of the patients. Patients’ dosing patterns often produced “uncovered” intervals (mean duration 3.7 days, range 0–25) with doubtful pharmacologic effectiveness. These lapses were underestimated by patients and poorly perceived by their treating physicians, despite familiarity with their care. Baseline sociodemographic, psychosocial, medical system, or clinical characteristics did not predict the patterns or degrees of medication noncompliance.

Conclusions: Major treatment gaps occur frequently, even in carefully selected ambulatory populations, and generally escape detection. The compliance patterns and gaps may contribute to reported excesses of cardiovascular morbidity and mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mushlin AI, Appel FA. Diagnosing patient noncompliance. Arch Intern Med. 1977;137:318–21.

    Article  PubMed  CAS  Google Scholar 

  2. Gilbert JR, Evans CE, Haynes RB, Tugwell P. Predicting compliance with a regimen of digoxin therapy in family practice. Can Med Assoc J. 1980;123:119–22.

    PubMed  CAS  Google Scholar 

  3. Caron HS. Compliance: the case for objective measurement. J Hypertens. 1985;3(suppl 1):11–7.

    Google Scholar 

  4. Kass MA, Gordon M, Meltzer DW. Can ophthalmologists correctly identify patients defaulting from pilocarpine therapy? Am J Ophthalmol. 1986;101:524–30.

    PubMed  CAS  Google Scholar 

  5. Eisen SA, Woodward RS, Miller D, Spitznagel E, Windham CA. The effect of medication compliance on the control of hypertension. J Gen Intern Med. 1987;2:298–305.

    Article  PubMed  CAS  Google Scholar 

  6. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. How often is medication taken as prescribed? A novel assessment technique. JAMA. 1989;261:3273–7.

    Article  PubMed  CAS  Google Scholar 

  7. Rudd P, Byyny RL, Zachary V, et al. The natural history of medication compliance in a drug trial: limitations of pill counts. Clin Pharmacol Ther. 1989;46:169–76.

    Article  PubMed  CAS  Google Scholar 

  8. Cramer JA, Scheyer RD, Mattson RH. Compliance declines between clinic visits. Arch Intern Med. 1990;150:1509–10.

    Article  PubMed  CAS  Google Scholar 

  9. Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med. 1990;150:1881–4.

    Article  PubMed  CAS  Google Scholar 

  10. Kruse W, Weber E. Dynamics of drug regimen compliance—its assessment by microprocessor-based monitoring. Eur J Clin Pharmacol. 1990;38:561–5.

    Article  PubMed  CAS  Google Scholar 

  11. Rudd P, Ahmed S, Zachary V, Barton C, Bonduelle D. Improved compliance measures: applications in an ambulatory hypertensive drug trial. Clin Pharmacol Ther. 1990;48:676–85.

    Article  PubMed  CAS  Google Scholar 

  12. Rudd P, Marshall G. Resolving problems of measuring compliance with medication monitors. J Compliance Health Care. 1987;2:23–35.

    Google Scholar 

  13. Maronde RF, Chan LS, Larsen FJ, Strandberg LR, Laventurier MF, Sullivan SR. Underutilization of antihypertensive drugs and associated hospitalization. Med Care. 1989;27:1159–66.

    Article  PubMed  CAS  Google Scholar 

  14. Psaty BM, Koepsell TD, Wagner ED, LoGerfo JP, Inui TS. The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers. JAMA. 1990;263:1653–7.

    Article  PubMed  CAS  Google Scholar 

  15. Shope JT. Compliance in children and adults: review of studies. Epilepsy Res. 1988;1(suppl 23):23–47.

    CAS  Google Scholar 

  16. Knight RA, Hay DA. The relevance of the health belief model to Australian smokers. Soc Sci Med. 1989;28:13H-4.

    Article  Google Scholar 

  17. Rangno RE, Langlois S. Comparison of withdrawal phenomena after propranolol, metoprolol and pindolol. Br J Clin Pharmacol. 1982;13(suppl 2):345S-351S.

    PubMed  CAS  Google Scholar 

  18. Houston MC, Hodge R. Beta-adrenergic blocker withdrawal syndromes in hypertension and other cardiovascular diseases. Am Heart J. 1988;116:515–23.

    Article  PubMed  CAS  Google Scholar 

  19. Gilligan DM, Chan WL, Stewart R, Oakley CM, Krikler S, Joshi J. Adrenergic hypersensitivity after beta-blocker withdrawal in hypertrophic cardiomyopathy. Am J Cardiol. 1991;68:766–72.

    Article  PubMed  CAS  Google Scholar 

  20. Rudd P. Blood pressure reduction and the risk of myocardial infarction. JAMA. 1990;263:660.

    Article  Google Scholar 

  21. Cruickshank JM. Coronary flow reserve and the J curve relation between diastolic blood pressure and myocardial infarction. BMJ. 1988;297:1227–30.

    PubMed  CAS  Google Scholar 

  22. Alderman MH, Ooi WL, Madhavan S, Cohen H. Treatment-induced blood pressure reduction and the risk of myocardial infarction. JAMA. 1989;262:920–4.

    Article  PubMed  CAS  Google Scholar 

  23. Berglund G. Goals of antihypertensive therapy: is there a point beyond which pressure reduction is dangerous? Am J Hypertens. 1989;2:586–98.

    PubMed  CAS  Google Scholar 

  24. Kass MA, Meltzer DW, Gordon M, Cooper D, Goldberg J. Compliance with topical pilocarpine treatment. Am J Ophthalmol. 1986;101:515–23.

    PubMed  CAS  Google Scholar 

  25. Gordon ME, Kass MA. Validity of standard compliance measures in glaucoma compared with an electronic eyedrop monitor. In: Cramer JA, Spilker B (eds). Patient Compliance in Medical Practice and Clinical Trials. New York: Raven Press, 1991;163–73.

    Google Scholar 

  26. Cramer JA, Mattson RH. Monitoring compliance with antiepileptic drug therapy. In: Cramer JA, Spilker B (eds). Patient Compliance in Medical Practice and Clinical Trials. New York: Raven Press, 1991; 123–37.

    Google Scholar 

  27. Johnston GD, Kelly JG, McDevitt DG. Do patients take digoxin? Br Heart J. 1978;40:1–7.

    PubMed  CAS  Google Scholar 

  28. Squire A, Goldman ME, Kupersmith J, Stern EH, Fuster V, Schweitzer P. Long-term antiarrhythmic therapy. Problem of low drug levels and patient noncompliance. Am J Med. 1984;77:1035–8.

    Article  PubMed  CAS  Google Scholar 

  29. Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med. 1990;150:841–5.

    Article  PubMed  CAS  Google Scholar 

  30. Sampson JJ, Arbona CL. Causes and effects of noncompliance in cardiac patients. Clin Cardiol. 1980;3:207–10.

    PubMed  CAS  Google Scholar 

  31. Levine AM, Richardson JL, Marks G, et al. Compliance with oral drug therapy in patients with hematologic malignancy. J Clin Oncol. 1987;5:1469–76.

    PubMed  CAS  Google Scholar 

  32. Richardson JL, Shelton DR, Krailo M, Levine AM. The effect of compliance with treatment on survival among patients with hematologic malignancies. J Clin Oncol. 1990;8:356–64.

    PubMed  CAS  Google Scholar 

  33. Didlake RH, Dreyfus K, Kerman RH, Van Buren CT, Kahan BD. Patient noncompliance: a major cause of late graft failure in cyclosporine-treated renal transplants. Transplant Proc. 1988;20(suppl 3):63–9.

    PubMed  CAS  Google Scholar 

  34. Rovelli M, Palmeri D, Vossler E, Bartus S, Hull D, Schweizer R. Noncompliance in organ transplant recipients. Transplant Proc. 1989;21(1):833–4.

    PubMed  CAS  Google Scholar 

  35. Schweizer RT, Rovelli M, Palmeri D, Vossler E, Hull D, Bartus S. Noncompliance in organ transplant recipients. Transplantation. 1990;49(2):374–7.

    Article  PubMed  CAS  Google Scholar 

  36. Muller JE, Tofler GH, Willich SN, Stone PH. Circadian variation of cardiovascular disease and sympathetic activity. J Cardiovasc Pharmacol. 1987;10(suppl 2):S104-S109.

    PubMed  Google Scholar 

  37. Muller JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation. 1989;79:733–43.

    PubMed  CAS  Google Scholar 

  38. Tofler GH, Stone PH, Maclure M, et al. Analysis of possible triggers of acute myocardial infarction (the MILIS study). Am J Cardiol. 1990;66:22–7.

    Article  PubMed  CAS  Google Scholar 

  39. Rudd P, Ahmed S, Zachary V, Barton C, Bonduelle D. Compliance with medication-timing: implications from a medication trial for drug development and clinical practice. J Clin Res Pharmacoepidemiol. 1992;6(3):15–27.

    Google Scholar 

  40. Rudd P, Ahmed, S, Zachary V, Barton C, Bonduelle D. Issues in patient compliance: the search for therapeutic sufficiency. Cardiology. 1992;80(suppl 1):2–10.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. the Department of Medicine, Stanford University Medical Center, USA

    Peter Rudd MD

  2. the Stanford University School of Medicine, Stanford

    David Guerrero

  3. the Department of Medicine, Kaiser Permanente Medical Center, Santa Clara

    Jaishri Ramesh MD

  4. the Division of Product Safety & Compliance (Unified Corporate Safety Database), Syntex Corporation, Palo Alto, California

    Colleen Bryant-Koslinc RN

Authors
  1. Peter Rudd MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jaishri Ramesh MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Colleen Bryant-Koslinc RN
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David Guerrero
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rudd, P., Ramesh, J., Bryant-Koslinc, C. et al. Gaps in cardiovascular medication taking. J Gen Intern Med 8, 659–666 (1993). https://doi.org/10.1007/BF02598282

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02598282

Key words

Search

Navigation